Hellp Syndrome
📧 Sign up to get email alerts when something new happens for Hellp Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Vitamin D Supplementation Among Pregnant Women in Uganda for the Prevention of Hypertensive Disorders in Pregnancy, and Other Adverse Maternal and Foetal Outcomes [Phase 4]
Phase 4 clinical trial in Uganda evaluating Vitamin D supplementation in pregnant women to prevent hypertensive disorders of pregnancy (pree…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Study of Prognostic Values of Platelet Indices and Inflammatory Markers in Patients With HELLP Syndrome.
This clinical trial from Sohag University investigates the prognostic value of platelet indices and inflammatory markers in HELLP syndrome a…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: sCD163 in HELLP Syndrome
A clinical trial investigating soluble CD163 (sCD163) in HELLP syndrome during pregnancy is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Pilot Project Renal and Cardiovascular Tertiary Prevention in Preeclampsia
A pilot trial on renal and cardiovascular tertiary prevention in preeclampsia is currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis
A recruiting clinical trial at Maastricht University Medical Center is investigating placental acute atherosis as a reflection of subclinica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-27Clinical Trial Update: MIRACLE of LIFE Study
Mirvie's MIRACLE of LIFE clinical trial update indicates the study is currently active but not recruiting, focusing on pregnancy outcomes re…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Preeclampsia Intervention Netherlands [Phase 3]
Phase 3 clinical trial in the Netherlands for a preeclampsia intervention; currently not yet recruiting.